Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-31
2011-05-31
Loewe, Sun Jae Y (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S304400
Reexamination Certificate
active
07951829
ABSTRACT:
The invention is directed to compounds of Formula (I):to pharmaceutical compositions containing such compounds and to methods of treatment using them.
REFERENCES:
patent: 6299796 (2001-10-01), Igarashi
Newman et al., DDT vol. 8, Oct. 2003, p. 898-90.
Chawla et al., CRIPS vol. 5, No. 1, Jan.-Mar. 2004, p. 9-12.
Boyd et al., caplus an 1995:252332.
Alzheimer's Disease Treatment Phases, http://www.alzheimerstreatment.org/treatment/disease-treatment.htm.
Alzheimer's Drugs, Consumer Reports Best Buy Drugs (p. 1-5).
CriticalReviewControlledClinicalTrials, http://www.ncbi.nlm.nih.gov/pubmed/9415498.
Chroic Pain, http://en.wikipedia.org/wiki/Chronic—pain (2010).
Gunthorpe et al., The Journal of Pharmacology and Experimental Therapeutics, 321, 2007, 1183-1192.
Alzheimer's Disease Treatment Phases, http://www.alzheimerstreatment.org/treatment/disease-treatment.htm (2009).
Alzheimer's Drugs, Consumer Reports Best Buy Drugs (p. 1-5) (2009).
CriticalReviewControlledClinicalTrials, http://www.ncbi.nlm.nih.gov/pubmed/9415498 (2009).
Yiangou, Y.; Facer, P.; Dyer, N. H.; Chan, C. L.; Knowles, C.: Williams, N. S.; Anand, P. Lancet 2001, 357, 1338-1339.
McVey, D. C.; Schmid, P. C.; Schmid, H. H. O.; Vigna, S. R. J. Pharmacol. Exp. Ther. 2003, 304, 713-722.
Kimball, E. S.; Wallace, N. H.; Schneider, C. R.; D'Andrea, M. R.; Hornby, P. J. Neurogasteroenterology 2004, 16, 811-818.
Walker, K. M.; Urban, L.; Medhurst, S. J.; Patel, S.; Panesar, M.; Fox, A. J.; McIntyre, P. J. Pharmacol. Exp. Ther. 2003, 304, 56-62.
Pomonis, J. D.; Harrison, J. E.; Mark, L.; Bristol, D. R.; Valenzano, K. J.; Walker, K. J. Pharmacol. Exp. Ther. 2003, 306, 387-393.
Lida, T.; Shimizu, I.; Nealen, M. L.; Campbell, A.; Caterina, M. Neurosci. Lett. 2005, 378, 28-33.
Ohnluki, K.; Haramizu, S.; Watanabe, T.; Yazawa, S.; Fushiki, T. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47, 295-298.
Woods, A. J.; Stock, M. J.; Gupta, A. N.; Wong, T. T. L.; Andews, P. L. R. Eur. J. Pharmacol. 1994, 264, 125-133.
Romanovsky, A. A. Frontiers in Bioscience 2004, 9, 494-504.
Nault, M. A.; Vincent, S. G.; Fisher, J. T. J. Physiol. 1999, 515, 567-578.
Jia, Y.; McLeod, R. L.; Wang, X.; Parra, L. E.; Egan, R. W.; Hey, J. A. Brit. J. Pharmacol. 2002, 137, 831-836.
Bianco, E. D.; Geppetti, P.; Zippi, P.; Isolani, D.; Magini, B.; Cappugi, P. Brit J of Clin Pharmacol 1996, 41, 1-6.
Kissin, I.; Bright, C. A.; Bradley, E. L., Jr. Anesth Analg 2002, 94, 1253-1258.
Ellison, N., Loprinzi, C. L., Kugler, J., Hatfield, A.K., Miser, A., Sloan, J.A., Wender, D.B., Rowland, K.M., Molina, R., Cascino, T.L., Vukov, A.M., Dhaliwal, H.S. and Ghosh, C.J. Clin. Oncol. 15:2974-2980, 1997.
Berger, A., Henderson, M., Naadoolman, W., Duffy, V., Cooper, D., Saberski, L., and Bartoshuk, L. J. Pain Sympt. Mgmt 10:243-248, 1995.
Avelino, A.; Cruz, F.; Coimbra, A. Eur. J Pharmacol. 1999, 378, 17-22.
Chancellor, M. B.; De Groat, W. C. J. Urol. (Baltimore) 1999, 162, 3-11.
Komiyama, I.; Igawa, Y.; Ishizuka, O.; Nishizawa, O.; Andersson, K.-E. J. Urol. (Baltimore) 1999, 161, 314-319.
de Seze, M; Wiart, L.; de Seze, M.-P.; Soyeur, L.; Dosque, J.-P; Blajezewski, S.; Moore, N.; Brochet, B.; Mazaux, J.-M.; Barat, M.; Joseph, P.-A. Journal of Urology (Hagerstown, MD, United States) 2003, 171, 251-255.
Li, J.; Kaminski, N. E.; Wang, D. H. Hypertension 2003, 41, 747-762.
Yamamoto, H.; Horie, S.; Uchida, M.; Tsuchiya, S.; Murayama, T.; Watanabe. K. Eur. J. Pharmacol. 2001, 432, 203-210.
Kasckow, J.W.; Muchahey, J.J; Geracioti, T.D. Jr. Progress in Neuro-Psychopharmacol. and Biological Psychiatry 2004, 28, 291-295.
Prieto, M. et al.,J. Org. Chem.2004, 69: 6812-6820.
Burger, A. et al.J. Med. Chem.1970, 13, 33-35.
Mitsunobu, O.,Synthesis, 1981, 1-28.
Mattson, R. J. et al.J. Org. Chem., 1990, 55, 2552-2554.
McElvain, S. M. et al.J. Am. Chem. Soc.1942, 64, 1825.
Komoriya et al.Bioorg. Med. Chem., 2004, 12, 2099-2114.
Evans, D.A.; Woerpel, K.A.; Hinman, M.M.; Faul, M.M.J. Am. Chem. Soc.1991, 113, 726-728.
Brennan. T.J. et al.,Pain,1996, 64: 493-501.
Beauchamp Derek A.
Brandt Michael Richard
Calvo Raul R.
Cheung Wing S.
Dax Scott L.
Dodd Thomas J.
Janssen Pharmaceutica NV
Loewe Sun Jae Y
LandOfFree
Benzimidazole modulators of VR1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole modulators of VR1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole modulators of VR1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695642